SCHEMBL680758

SCHEMBL680758

Cc1cccc(Oc2ccc(C(=O)NS(C)(=O)=O)cc2)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
POLB P06746 1/20 0.51
GAA P10253 1/20 0.51
CRHBP P24387 1/20 0.51
FNTA P49354 1/20 0.51
FNTB P49356 1/20 0.51
CRHR2 Q13324 1/20 0.51
DHFR P00374 1/20 0.48
SCN9A Q15858 6/20 0.44
MAPK14 Q16539 1/20 0.44
SCN3A Q9NY46 1/20 0.43
EZH2 Q15910 1/20 0.43
SCN2B O60939 1/20 0.42
SCN1A P35498 1/20 0.42
SCN1B Q07699 1/20 0.42
SCN5A Q14524 1/20 0.42
P4HTM Q9NXG6 2/20 0.42
PTPN1 P18031 1/20 0.41
BCL2L1 Q07817 2/20 0.41
MCL1 Q07820 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679956 0.89 MAPK14 (0.55) ALDH1A1GAASCN9AMAPK14SCN3A
SCHEMBL680489 0.85 SCN3A (0.45) SCN9ASCN3ASCN2BSCN1ASCN1B
SCHEMBL679939 0.81 MEN1 (0.60) ALDH1A1GAASCN9ASCN3AEZH2
SCHEMBL680339 0.80 KMT2A (0.51) ALDH1A1POLBGAASCN9ASCN3A
SCHEMBL681087 0.80 SCN9A (0.54) SCN9ASCN3ASCN2BSCN1BSCN5A
SCHEMBL680618 0.80 MAPK14 (0.54) SCN9AMAPK14SCN3AEZH2LMNA
SCHEMBL680159 0.80 CXCL8 (0.59) SCN9ASCN3ASCN2BSCN1BSCN5A
SCHEMBL10825678 0.79 DHFR (0.54) ALDH1A1POLBGAACRHBPFNTA
SCHEMBL680346 0.79 SCN9A (0.57) SCN9ASCN2BSCN1ASCN1BSCN5A
SCHEMBL679137 0.79 RORC (0.52) SCN9AMAPK14SCN3ASCN5APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 EP disclosed
US-20120010207-A1 Chemical Compounds PFIZER LIMITED (GB) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010207-A1 Chemical Compounds SCN1A, SCN1B, SCN7A ALDH1A1 643/4885POLB 4438/4885GAA 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.